Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1166.0000 -6.70 (-0.57%)
NSE Jan 19, 2026 15:27 PM
Volume: 529.5K
 

1166.00
-0.57%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. is trading above its 200 day SMA of 1145.0
More from Aurobindo Pharma Ltd.
Recommended